How Much Does Tirzepatide Cost Without Insurance? (2026 Telehealth Pricing)

Without insurance, brand-name Zepbound vials cost $299 to $449 a month through Lilly's self-pay pharmacy, depending on the dose^2,3. Compounded tirzepatide from telehealth providers commonly runs about $145 to $349 a month. Tirzepatide usually costs more than semaglutide at the same provider, so compare the ongoing monthly price, not a first-month offer.

The main billing question is how the advertised monthly amount relates to the payment you must make. Zepbound self-pay prices depend on dose, while telehealth programs may quote a starting dose, an introductory rate or an average that requires prepayment. The provider prices below were reviewed in 2026. Check the individual review's date and terms, then confirm your prescribed dose and continuing bill before enrolling.

If you plan to pay with benefits funds, read HSA and FSA rules for GLP-1 expenses. Confirm which charges qualify and keep receipts for the amount you actually paid.

The short answer

Without insurance, brand-name tirzepatide (Zepbound) single-dose vials now run about $299 to $449 a month through the manufacturer's self-pay pharmacy depending on dose^2,3, down sharply from a retail list price around $1,086 a month. Compounded tirzepatide through a telehealth provider commonly runs about $145 to $349 a month, with a few disclosed prices lower and premium tiers at the top of that band. The published prices covered here span roughly $110 to $449 a month. Before comparing those figures, confirm the prescribed dose and formulation, how much you pay at renewal, and whether a multi-month purchase is required. Tirzepatide typically costs more than semaglutide at the same provider. TrumpRx.gov points to the same manufacturer price for Zepbound; our guide to TrumpRx GLP-1 prices vs. telehealth shows which doses each listed price actually covers.

Brand-name Zepbound: list price vs. the new self-pay price

Zepbound is FDA-approved tirzepatide, indicated as an adjunct to diet and exercise for chronic weight management¹. Its retail list price has sat around $1,086 a month, the number that kept cash payers away.

That's changed. Through Eli Lilly's direct self-pay channel, single-dose Zepbound vials are sold to cash patients at reduced monthly prices tiered by dose — roughly $299 a month for the 2.5 mg starter, about $399 for 5 mg, and about $449 for the higher doses, when refilled on schedule^2,3. These vials are a cash-only product — no insurance and no pharmacy discount cards apply — but they get you the FDA-approved medication for roughly a quarter of the retail pen price³. In other words, buying the brand for cash is far cheaper than it used to be. Our LillyDirect Zepbound price guide lists the vial and KwikPen price at every dose and what a late refill costs.

Compounded tirzepatide: what telehealth actually charges

Compounded tirzepatide is prepared by a licensed pharmacy rather than sold as an FDA-approved finished product; FDA does not review its safety, effectiveness, or quality before it reaches patients⁴. This difference in regulatory review does not by itself explain a provider's price or establish that compounding is appropriate for you. Across the telehealth providers we track, compounded tirzepatide most commonly lands in the $145–$349 a month band. At the low end, a few providers disclose prices around $110–$166; in the middle sit a cluster of plans around $199–$299; and premium or brand-adjacent tiers reach $349–$399.

For a concrete anchor: CoreAge Rx prices compounded tirzepatide at $149 a month flat, the same molecule that costs far more as brand, with no intro-rate step-up. You can line up every provider's real tirzepatide price with our cost calculator, which pulls the same disclosed numbers and lets you total them over 3, 6, or 12 months. Or browse the full cash-pay GLP-1 ranking for nationwide, no-lock-in and brand-name picks.

Two sellers show how differently the same band gets presented. Trellis Vitality's published 1/3/6-month table puts compounded tirzepatide at $199 a month and labels the one-month column as month-to-month, which is precisely the disclosure most price pages skip. Auren Rx's no-commitment price is $259 against its own $229 subscription rate — and the product markup it hands to search engines carries the $229, so anything reading the page mechanically records a number you can only get by subscribing. Read the term, not the figure.

What drives the price range

Four things move a compounded price:

The medication and dose. Tirzepatide is generally priced above semaglutide, and higher maintenance doses can cost more at some pharmacies — though many telehealth plans charge one flat monthly price regardless of dose.

Whether it's a teaser or a maintenance price. Some providers advertise a low first-month rate that steps up sharply afterward. Because a GLP-1 is usually a multi-year commitment, the maintenance price — not the intro rate — is the number that matters.

What's bundled in. A plan that includes clinician visits, dose adjustments, labs, and shipping can be cheaper in total than a lower sticker that bills those separately.

Brand vs. compounded, and legal basis. Tirzepatide's shortage-based enforcement-discretion periods ended in 2025. FDA's April 2026 update says tirzepatide is on neither its shortage list nor the 503B bulks list, and patient-specific compounding under section 503A must meet restrictions on products that are essentially copies of commercially available drugs⁵. A low advertised price does not establish that a prescription meets those conditions. Ask the prescriber and dispensing pharmacy why a compounded preparation is appropriate for your medical needs; our guide to compounded vs. brand-name GLP-1s explains the distinction.

What's included — consult, labs, and shipping

For a tirzepatide quote, separate the medication charge from the cost of clinical care. Ask whether the bill includes the initial written or live consultation, the prescription, ongoing dose adjustments and shipping. Required baseline labs may be included or billed separately. Add those charges before comparing the quote with an all-in program in the comparison hub. If you already have a prescription and are changing services, the provider-switching checklist covers the records, refill and billing questions to resolve before your next renewal.

Plan-length discounts and the maintenance-price trap

Almost every telehealth provider discounts longer commitments: paying quarterly or for a full course usually beats month-to-month. That can be a real saving if you're confident tirzepatide is right for you — but prepaying also locks you in, so it cuts both ways. A site may show only the discounted plan: MyDrHank publishes tirzepatide "from $240/mo", which is a $2,883 payment for twelve months up front — its month-to-month rate is $349 and appears on no page at all. Some providers have no month-to-month payment option: Pallas Health advertises tirzepatide at "$299/mo average", but its funnel offers only a 12-week prepay, so the actual charge is $897 every twelve weeks and the advertised figure is that payment divided by three. The pattern repeats often enough to be worth recognizing on sight. SkinnyRx advertises tirzepatide "as low as $299/mo", which is its twelve-month plan charged as $3,588 on day one; paying by the month costs $399. Try Ageless leads with "FROM $249/mo" on the same molecule, which is likewise the yearly rate — $2,988 up front — against a month-to-month price of $349. A default can do the same work as a headline: RxSpan MD's plan selector arrives pre-set to a three-month prepay rather than to Monthly, so clicking straight through commits you to $927 rather than $329. In each case a monthly number exists; it is simply not the one the page shows you first. The bigger trap is the teaser rate. A plan advertised at a low first month that becomes far more for months two onward is really priced at the ongoing number. Always find the ongoing price and multiply it out; our guide to picking a provider for long-term use explains why the maintenance number is the one that matters.

HSA/FSA and other ways to lower the cost

Tirzepatide prescribed for a diagnosed medical condition is generally an eligible expense for an HSA or FSA, letting you pay with pre-tax dollars and effectively shave your marginal tax rate off the price — worth confirming with your plan administrator. Beyond that: choose an all-in flat plan to avoid surprise add-ons, use manufacturer self-pay pricing if you want the brand, use plan-length discounts only once you're committed, and compare the maintenance price rather than the intro rate. If you're also weighing semaglutide — which is usually cheaper — our semaglutide vs. tirzepatide guide covers the price and efficacy trade-off, and semaglutide cost without insurance breaks down that molecule.

So what should you actually budget?

Tirzepatide is the higher-efficacy molecule — SURMOUNT-1 showed average weight loss up to roughly 21% at the top dose⁶ — and it typically costs more than semaglutide to match. For most cash payers, a realistic 2026 budget is about $200 to $350 a month for a solid, all-in compounded tirzepatide program, or roughly $299 to $449 a month for FDA-approved Zepbound vials through the manufacturer's self-pay pharmacy^2,3. Below roughly $150 you can find legitimate compounded options in some states, but scrutinize what's bundled and whether the price is a teaser.

Not sure which plan fits your budget and molecule? The 2-minute quiz weighs budget, molecule, and support into our honest Match Score and surfaces providers that fit, our best tirzepatide providers — one of several rankings on our rankings hub — ranking ranks the field, or you can run the numbers yourself in the cost calculator. You can also weigh the flat-price provider featured below.